Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ideal Option is a leading provider of outpatient medication-assisted treatment (MAT) for individuals suffering from substance use disorders, primarily opioid and alcohol addiction. Founded in 2012 by emergency medicine physicians, the company operates an extensive network of specialized clinics across the United States. Their evidence-based clinical model utilizes FDA-approved medications such as buprenorphine and naltrexone, integrated with frequent medical monitoring and laboratory testing. The company emphasizes low-barrier access to care, often offering same-day appointments to facilitate immediate intervention and long-term recovery. Ideal Option's mission is to provide high-quality, compassionate care to underserved populations affected by the opioid epidemic.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ideal Option.